Abstract
Excision repair cross complementation group 1 (ERCC1) is an important protein in the nucleotide excision repair (NER) pathway, which is responsible for removing DNA adducts induced by platinum based compounds. The heterodimer ERCC1-XPF is one of two endonucleases required for NER. Genetic variations or polymorphisms in ERCC1 gene alter DNA repair capacity. Reduced DNA repair (NER) capacity may result in tumors and enhances cisplatin chemotherapy in cancer patients, which functions by causing DNA damage. Therefore, ERCC1 variants have the potential to be used as a strong candidate biomarker in cancer treatments. In this study we identified five variants V116M, R156Q, A199T, S267P, and R322C of ERCC1 gene as highly deleterious. Further structural and functional analysis has been conducted for ERCC1 protein in the presence of three variants V116M, R156Q, and A199T. Occurrence of theses variations adversely affected the regular interaction between ERCC1 and XPF protein. Analysis of 20 ns molecular dynamics simulation trajectories reveals that the predicted deleterious variants altered the ERCC1-XPF complex stability, flexibility, and surface area. Notably, the number of hydrogen bonds in ERCC1-XPF mutant complexes decreased in the molecular dynamic simulation periods. Overall, this study explores the link between the ERCC1 deleterious variants and cisplatin chemotherapy for various cancers with the help of molecular docking and molecular dynamic approaches.
Similar content being viewed by others
References
De Laat, W. L., Appeldoorn, E., Jaspers, N. G., & Hoeijmakers, J. H. (1998). The Journal of Biological Chemistry, 273, 7835–7842.
Volker, M., Mone, M. J., Karmakar, P., van Hoffen, A., Schul, W., Vermeulen, W., et al. (2001). Molecular Cell, 8, 213–224.
De Boer, J., & Hoeijmakers, J. H. (2000). Carcinogenesis, 21, 453–460.
Jaspers, N. G., Raams, A., Silengo, M. C., Wijgers, N., Niedernhofer, L. J., Robinson, A. R., et al. (2007). American Journal of Human Genetics, 80, 457–466.
Chen, P., Wiencke, J., Aldape, K., Kesler Diaz, A., Miiker, R., Kelsey, K., et al. (2000). Cancer Epidemiology, Biomarkers & Prevention, 9, 843–847.
Yu, J. J., Lee, K. B., Mu, C., Li, Q., Abernathy, T. V., et al. (2000). International Journal of Oncology, 16, 555–560.
Bradbury, P. A., Kulke, M. H., Heist, R. S., Zhou, W., Ma, C., Xu, W., et al. (2009). Pharmacogenetics and Genomics, 19(8), 613–625.
Sunyaev, S., Hanke, J., Aydin, A., Wirkner, U., Zastrow, I., Reich, J., et al. (1999). Journal of Molecular Medicine, 77, 754–760.
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., et al. (1999). Nature Genetics, 22, 231–238.
Chasman, D., & Adams, R. M. (2001). Journal of Molecular Biology, 307, 683–706.
Ng, P. C., & Henikoff, S. (2001). Genome Research, 11, 863–874.
Wang, Z., & Moult, J. (2001). Human Mutation, 17, 263–270.
Ng, P. C., & Henikoff, S. (2006). Annual Review of Genomics and Human Genetics, 7, 61–80.
Mooney, S. (2005). Briefings in Bioinformatics, 6, 44–56.
Steward, R. E., MacArthur, M. W., Laskowski, R. A., & Thornton, J. M. (2003). TrendsGenetics, 19, 505–513.
Laskowski, R. A., & Thornton, J. M. (2008). Nature Reviews Genetics, 9, 141–151.
Pruitt, K. D., Tatusova, T., & Maglott, D. R. (2007). Nucleic Acids Research, 35, 61–65.
Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., et al. (2000). Nucleic Acids Research, 28, 235–242.
Amos, B., & Rolf, A. (1996). Nucleic Acids Research, 24, 21–25.
Tsodikov, O. V., Enzlin, J. H., Scharer, O. D., & Ellenberger, T. (2005). Proceedings of the National Academy of Sciences of the United States of America, 102, 11236–11241.
Kaplan, W., & Littlejohn, T. G. (2001). Briefings in Bioinformatics, 2, 195–197.
Kumar, P., Henikoff, S., & Ng, P. C. (2009). Nature Protocols, 4, 1073–1081.
Mi, H., Guo, N., Kejariwal, A., & Thomas, P. D. (2007). Nucleic Acids Research, 35, 247–252.
Capriotti, E., Fariselli, P., Rossi, I., & Casadio, R. (2008). BMC Bioinformatics, 9(Suppl 2):S6
Ramensky, V., Bork, P., & Sunyaev, S. (2002). Nucleic Acids Research, 30, 3894–3900.
Ng, P. C., & Henikoff, S. (2003). Nucleic Acids Research, 13, 3812–3814.
Dominguez, C., Boelens, R., & Bonvin, A. M. (2003). Journal of the American Chemical Society, 125, 1731–1737.
de Vries, S. J., van Dijk, M., & Bonvin, A. M. J. J. (2010). Nature Protocols, 5, 883–897.
Nilges, M. (1995). Journal of Molecular Biology, 245, 645–660.
Nilges, M., Macias, M. J., O’Donoghue, S. I., & Oschkinat, H. (1997). Journal of Molecular Biology, 269, 408–422.
Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., et al. (1998). Acta Crystallographica. Section D, Biological Crystallography, 54, 905–921.
Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008). Journal of Chemical Theory and Computation, 4, 435–447.
Kutzner, C., van der Spoel, D., Fechner, M., Lindahl, E., Schmittn, U. W., de Groot, B. L., et al. (2007). Journal of Compound Chemistry, 28, 2075–2084.
Van Gunsteren, W.F., Billeter, S.R., Eising, A.A., Hunenberger, P.H., & Kruger, P. (1996). Zurich, Groningen
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). The Journal of Chemical Physics, 79, 926.
Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). The Journal of Chemical Physics, 81, 3684–3690.
Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). The Journal of Chemical Physics, 103, 8577–8593.
Case, D.A., Pearlman, D.A., Caldwell, J.W., Wang, J., Ross, W.S., Simmerling, T.A., et al. (2002). San Francisco, CA, University of California
Baker, E. N., & Hubbard, R. E. (1984). Progress in Biophysics and Molecular Biology, 44, 97–179.
Halperin, I., Ma, B., Wolfson, H., & Nussinov, R. (2002). Proteins: Structure, Function, and Genetics, 47, 409–443.
Janin, J., Henrick, K., Moult, J., Eyck, L. T., Sternberg, M. J., Vajda, S., et al. (2003). Proteins: Structure, Function, and Genetics, 52, 2–9.
Dominguez, C., Boelens, R., & Bonvin, A. M. (2003). Journal of the American Chemical Society, 125, 1731–1737.
Teng, S., Madej, T., Panchenko, A., & Alexov, E. (2009). Biophysical Journal, 96(6), 2178–2188.
Zhang, Z., Norris, J., Schwartz, C., & Alexov, E. (2011). PLoS One, 6(5), e2037.
Garcia, A. E. (1992). Physical Review Letters, 68, 2696–2699.
Cui, Q., & Bahar, I. (2006). Chapman & Hall/CRC. FL: Boca Raton.
Pimentel, G.C., & McClellan, A.L. (1960). Freeman: San Francisco
Desiraju, G., & Steiner, T. (1999). Oxford University Press: Oxford
Schuster, P., Zundel, G., & Sandorfy, C. (1976). Elsevier Science Publishing. Amsterdam: North-Holland.
Gerlt, J. A., Kreevoy, M. M., Cleland, W. W., & Frey, P. A. (1997). Chemistry and Biology, 4, 259–267.
Becker, O., Mackerell, A., Roux, B., Watanabe, M., & Eds. (2001). Computational Biochemistry & Biophysics, Marcel Dekker, New York
Eisenberg, D., & McClachlan, A. (1986). Nature, 319, 199–203.
Wesson, L., & Eisenberg, D. (1992). Protection Science, 1(2), 227–235.
Fraternali, F., & van Gunsteren, W. (1996). Journal of Molecular Biology, 256, 939–948.
Ferrara, P., Apostolakis, J., & Caflisch, A. (2002). Proteins, 46, 24–33.
Koehl, P., & Delarue, M. (1994). Proteins, 20, 264–278.
Bradbury, P. A., Kulke, M. H., Heist, R. S., Zhou, W., Ma, C., Xu, W., et al. (2009). Pharmacogenet Genomics, 19(8), 613–25.
Bradbury, P. A., Kulke, M. H., Heist, R. S., Zhou, W., Ma, C., Xu, W., et al. (2009). Pharmacogenetics and Genomics, 19(8), 613–625.
Giovannetti, E., Pacetti, P., Reni, M., Leon, L. G., Mambrini, A., Vasile, E., et al. (2011). Pharmacogenomics, 12, 1641–1652.
Wang, Z., & Moult, J. (2001). Human Mutation, 17, 263–270.
George Priya Doss, C., Sudandiradoss, C., Rajasekaran, R., Purohit, R., Ramanathan, K., & Sethumadhavan, R. (2008). Journal of Biomedical Informatics, 41, 607–612.
Nagasundaram, N., & Priya Doss, C. G. (2011). Journal Carcinogenesis, 10, 26.
Doss, C. G., & Nagasundaram, N. (2012). PLoS One, 7(2), e31677.
Mohamed, A. J., Yu, L., Backesjo, C. M., Vargas, L., & Faryal, R. (2009). Immunological Reviews, 228, 58–73.
Muller, C. W., Schlauderer, G. J., Reinstein, J., & Schulz, G. E. (1996). Structure, 4, 147–156.
Vihinen, M. (1987). Protein Engineering, 1, 477–480.
Bikadi, Z., Demko, L., & Hazai, E. (2007). Archives of Biochemistry and Biophysics, 461, 225–234.
Ahmad, S., Gromiha, M. M., & Sarai, A. (2004). Bioinformatics, 20, 477–486.
International HapMap Consortium. (2005). Nature, 27,437(7063).
Collins, F. S., Guyer, M. S., & Charkravarti, A. (1997). Science, 278, 1580–1581.
Acknowledgments
The authors take this opportunity to thank the management of Vellore Institute of Technology University for providing the facilities and encouragement to carry out this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
C, G.P.D., N, N. Molecular Docking and Molecular Dynamics Study on the Effect of ERCC1 Deleterious Polymorphisms in ERCC1-XPF Heterodimer. Appl Biochem Biotechnol 172, 1265–1281 (2014). https://doi.org/10.1007/s12010-013-0592-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-013-0592-5